Tenax Therapeutics to present Phase 3 LEVEL results at ESC Congress 2026

Verifying
  • Tenax Therapeutics announced a presentation of Phase 3 LEVEL results.
  • The presentation is scheduled for ESC Congress 2026.
  • The results will appear in late-breaking scientific sessions.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.